The future of Covid-curbing
We know less about the future of the Omicron variant of the virus behind Covid than do the scientists who insist that it will be weeks before a clear picture. But from what the scientists are reasonably sure of, already some political conclusions follow. The months for which governments have stalled demands to requisition Big Pharma assets — at least the patents and the technical know-how which would allow ultra-fast worldwide expansion of vaccine production and distribution — will now take a toll in Africa. The world jab rate has been more or less static, around 0.4 doses per 100 people per...